We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

212 hedge funds and large institutions have $2.42B invested in Select Medical in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 70 increasing their positions, 80 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

8% more capital invested

Capital invested by funds: $2.23B → $2.42B (+$186M)

0.33% more ownership

Funds ownership: 148.98%149.31% (+0.33%)

3% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 35

2% less funds holding

Funds holding: 216212 (-4)

13% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 80

83% less call options, than puts

Call options by funds: $785K | Put options by funds: $4.6M

Holders
212
Holders Change
-4
Holders Change %
-1.85%
% of All Funds
3.41%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
34
Increased
70
Reduced
80
Closed
35
Calls
$785K
Puts
$4.6M
Net Calls
-$3.81M
Net Calls Change
-$3.4M
Name Holding Trade Value Shares
Change
Change in
Stake
KBC Group
101
KBC Group
Belgium
$673K +$5.39K +417 +0.8%
AQR Capital Management
102
AQR Capital Management
Connecticut
$627K -$11.5K -891 -2%
Janus Henderson Group
103
Janus Henderson Group
$544K -$526K -40,657 -50%
MOACM
104
Mutual of America Capital Management
New York
$542K +$30.7K +2,378 +6%
Mackenzie Financial
105
Mackenzie Financial
Ontario, Canada
$492K +$476K +36,788 New
Bank of Montreal
106
Bank of Montreal
Ontario, Canada
$491K +$9.81K +759 +2%
Natixis Advisors
107
Natixis Advisors
Massachusetts
$487K -$14.2K -1,095 -3%
Grantham, Mayo, Van Otterloo & Co (GMO)
108
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$487K -$245K -18,931 -34%
SXL
109
Summit X LLC
Missouri
$474K +$7.25K +561 +2%
Arrowstreet Capital
110
Arrowstreet Capital
Massachusetts
$467K +$451K +34,885 New
HW
111
Hancock Whitney
Mississippi
$430K +$62.9K +4,868 +18%
OSAM
112
O'Shaughnessy Asset Management
Connecticut
$426K -$150K -11,637 -27%
LPL Financial
113
LPL Financial
California
$422K +$17.1K +1,325 +4%
Handelsbanken Fonder
114
Handelsbanken Fonder
Sweden
$415K
ProShare Advisors
115
ProShare Advisors
Maryland
$408K +$51.4K +3,979 +15%
BCI
116
Brinker Capital Investments
Pennsylvania
$408K +$37.3K +2,882 +10%
FM
117
Foster & Motley
Ohio
$396K -$75.8K -5,863 -17%
PI
118
Putnam Investments
Massachusetts
$383K -$155K -12,007 -30%
Public Employees Retirement Association of Colorado
119
Public Employees Retirement Association of Colorado
Colorado
$380K
ECM
120
EMC Capital Management
Texas
$380K +$55.2K +4,268 +18%
BNP Paribas Financial Markets
121
BNP Paribas Financial Markets
France
$362K -$655K -50,639 -65%
Zurich Cantonal Bank
122
Zurich Cantonal Bank
Switzerland
$358K
D.E. Shaw & Co
123
D.E. Shaw & Co
New York
$344K -$46.3K -3,582 -12%
Two Sigma Investments
124
Two Sigma Investments
New York
$343K +$331K +25,613 New
WG
125
Winton Group
United Kingdom
$340K +$328K +25,383 New

SEM Hedge Fund Activity: Q4 2022 in Review

212 of the 6,225 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q4 2022, worth a combined $2.42B — up 8.3% from $2.23B a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of SEM and 34 opened new positions — a net loss of 1 holder — while 80 trimmed existing stakes and 70 added.

The largest buyer was Hood River Capital Management, opening a new position worth an estimated $55.1M. The largest seller was Macquarie Group, cutting an estimated $41M.

  • 212 institutional investors held Select Medical (SEM) as of Q4 2022, down from 216 in Q3 2022.
  • Funds reported $2.42B of Select Medical stock for Q4 2022, up 8.3% quarter-over-quarter.
  • 34 funds opened new Select Medical positions in Q4 2022 and 35 closed out, a net change of -1 holder.
  • The largest Select Medical buyer in Q4 2022 was Hood River Capital Management, an estimated $55.1M added.
  • The largest Select Medical seller in Q4 2022 was Macquarie Group, an estimated $41M sold.

Based on aggregated 13F filings for Q4 2022.